about
From neurodegeneration to neurohomeostasis: the role of ubiquitinBcl-xL as an antiapoptotic molecule for cardiomyocytesG13-mediated signaling as a potential target for antiplatelet drugsChronicles in drug discoveryThe discovery and role of CD147 as a subunit of gamma-secretase complexTIRC7 pathway as a target for preventing allograft rejectionThe latest advances in kidney diseases and related disordersTherapeutic use of PDZ protein-protein interaction antagonismLysyl oxidase as a potential therapeutic targetCYBA gene variants as biomarkers for coronary artery diseaseAntagonists of the prostaglandin D2 receptor CRTH2The antipsychotic potential of muscarinic allosteric modulationImprovement of Endothelial Function by HMG-CoA Reductase InhibitorsPandemic preparedness: toward a universal influenza vaccine.Accelerating drug development and approval.Research paths to successful prevention and treatment of swine-derived H1N1 influenza virus infection.New music to an old melody: The 66th AAAAI meeting in New Orleans.Brown adipose tissue: a promising target to combat obesity.The significance of GlgE as a new target for tuberculosis.mGlu5 receptor antagonists: a novel class of anxiolytics?Quality and quantity of data.The role of mitochondrial dysfunction in bipolar disorder.Novel medicines from nature.The Role of Bioinformatics in Identifying and Defining Potential Drug Targets.The discovery and synthesis of epinephrine.JAK/STAT-dependent gene regulation by cytokines.The role of the endogenous cannabinoid system in drug addiction.New developments in thrombosis and coagulation therapy.Spotlight on rituximab as a new therapeutic option for dermatomyositis and thrombotic thrombocytopenic purpura.Live cell imaging for target and drug discovery.Biomarkers for Alzheimer's disease.Pin1 as an anticancer drug target.Magnetic resonance imaging biomarkers of ischemic stroke: criteria for the validation of primary imaging biomarkers.Disrupting the Rb-Raf-1 interaction: a potential therapeutic target for cancer.XF drugs: A new family of antibacterials.Biomarkers for multiple sclerosis.Asparagine synthetase: a new potential biomarker in ovarian cancer.The History of Thalidomide.JAK protein kinase inhibitors.The rise and fall of Dimebon.
P1433
Q28177500-F2D076A1-9DAE-4731-BD19-998222D8D2F6Q28190807-A4634B94-2CBE-4154-9D6E-797AF4072229Q28211909-FD2B0831-AE36-4129-9A83-BE01CEE07B46Q28212279-9BE4A23E-9EA8-49BE-A3D6-8366597467FAQ28248844-9D553613-E3D2-4DA0-B267-D5A82FCAB2BCQ28249525-0902BACC-9A2B-4807-BE9D-F80D1169E6E4Q28270219-FE38718E-5FE9-4E78-BD61-15D92B556642Q28284263-4B348EB3-5CC6-4DB5-AE69-0B5D7616EC79Q28284273-F1B0C52F-29EC-491F-900C-DFD2168E0336Q28287099-0DCB74D8-95F1-4C66-86C9-43FA7C33A5A9Q28296092-BC5D3408-D748-4B94-9235-379400A1E70EQ28603221-37A4119A-5052-4B54-B3B7-0F69E26F4CF7Q28645767-0ADA0545-F540-4D3E-8478-1DC8C6327B64Q30228108-202C4864-33A8-4B59-904F-6088203976FFQ30385630-E44C0AF0-51C0-4EF6-ADE6-69F0CAB48D0DQ30385633-8A5E9DDD-DC54-4B7E-8AB0-C63E08504F4FQ30388792-03E54E2D-657A-4C11-9A77-F0C44B0E57E7Q30394024-CF8E4D82-A585-4136-8054-8242E85371F2Q30397823-F3D735E8-F844-4FCA-BB81-6F8931EF2C03Q30954776-EEF7626B-F486-4AC1-87DC-4430D8AB9487Q30979157-ACCD6E73-6C45-4E39-946B-534779B11C35Q31100649-0D88105A-A55B-44A9-9D2D-B64FCA40CBCEQ31136864-7F0A08D4-84B7-4819-AE82-2830B08AFEABQ31137439-672D9612-1A52-46E9-A92A-7F3B8E908C0CQ33187389-BDF3EB1E-DE83-4BDA-86F2-237173047384Q33220017-AF2BE7D9-A395-4014-B5F9-F0FD711C17C3Q33344540-3C4B0C83-5F04-4EF7-AC71-0CA09022B3A9Q33364268-860CE58E-30C5-435E-B1DD-BDFDB119B030Q33373542-ACF99731-AB54-4CEF-9906-4565F5F1ACBBQ33423887-7A250667-B6A4-4445-A54E-2F8A31D0DC8EQ33445619-9913B84C-89E0-4484-A6A6-D1FDE503B648Q33515046-4584F54E-0BC5-4718-B112-9A26EBF214A9Q33519086-C08C01B6-2885-4082-AB50-680014E385FEQ33566343-485B21F7-F5AF-4EB4-9691-E6473CFB2826Q33571365-3FE821C0-F5F5-4DAF-8163-9159A7F884B6Q33770333-BF9FBB2E-CFA2-4492-A1F2-487EB4199361Q33894413-DD9DD0D6-8105-4609-8CCE-C3CA8CFE1DE7Q33965286-887AC72E-96ED-4761-AA7F-DB67FFF8A92AQ33990381-F7E7DF80-2E4A-4549-B176-50CE6A75747BQ34146766-CB05F45E-E79A-49BF-A007-90CB16F19665
P1433
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
Drug News and Perspectives
@ast
Drug News and Perspectives
@da
Drug News and Perspectives
@en
Drug News and Perspectives
@es
Drug News and Perspectives
@fi
Drug News and Perspectives
@fr
Drug News and Perspectives
@it
Drug News and Perspectives
@nb
Drug News and Perspectives
@nl
Drug News and Perspectives
@nn
type
label
Drug News and Perspectives
@ast
Drug News and Perspectives
@da
Drug News and Perspectives
@en
Drug News and Perspectives
@es
Drug News and Perspectives
@fi
Drug News and Perspectives
@fr
Drug News and Perspectives
@it
Drug News and Perspectives
@nb
Drug News and Perspectives
@nl
Drug News and Perspectives
@nn
altLabel
Drug News & Perspectives
@en
prefLabel
Drug News and Perspectives
@ast
Drug News and Perspectives
@da
Drug News and Perspectives
@en
Drug News and Perspectives
@es
Drug News and Perspectives
@fi
Drug News and Perspectives
@fr
Drug News and Perspectives
@it
Drug News and Perspectives
@nb
Drug News and Perspectives
@nl
Drug News and Perspectives
@nn
P3181
P4616
P1055
P1058
P1156
P1277
P1476
Drug News and Perspectives
@en